← Back to Search

Behavioral Intervention

Mindfulness-based therapy for insomnia (MBTI) for Insomnia

N/A

Waitlist Available

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a treatment called Mindfulness Based Therapy for Insomnia (MBTI) can help black women who have trouble sleeping. MBTI involves meditation and learning better sleep habits to help improve sleep quality. Mindfulness-Based Therapy for Insomnia (MBTI) has been shown to help people fall asleep faster and feel better about their sleep in older adults with sleep disturbances.

Eligible Conditions

Insomnia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Fidelity

Change in Insomnia severity score

Change in perceived stress score (PSS)

+6 more

Secondary study objectives

Change in C-reactive protein [CRP]

Change in Cortisol

Change in Five Facet Mindfulness Questionnaire (FFMQ)

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindfulness-based therapy for insomnia (MBTI)Experimental Treatment1 Intervention

Participants randomly assigned to the MBTI will receive 2 hours weekly session of mindfulness meditation and behavioral sleep strategies for 8 weeks.

Group II: Healthy Lifestyle EducationActive Control1 Intervention

Participants in the control group will receive sessions on the following topics: Introduction to health promotion, disease prevention and screening, healthy eating, physical activity, communication, and endings.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness-based therapy for insomnia (MBTI)

2022

N/A

~30

Do I qualify?Apply below to find out